<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27-viruses-11-00928">
 <label>27.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Uraki</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kiso</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Iwatsuki-Horimoto</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Fukuyama</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Takashita</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Ozawa</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kawaoka</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges</article-title>
  <source>J. Virol.</source>
  <year>2013</year>
  <volume>87</volume>
  <fpage>7874</fpage>
  <lpage>7881</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.00076-13</pub-id>
  <pub-id pub-id-type="pmid">23658445</pub-id>
 </element-citation>
</ref>
